Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Publications

The Access to Medicine Foundation's Strategic Direction 2022-2026

The Strategic Direction for 2022-2026 provides an overview of the Access to Medicines Foundation's plans for the future, and how we will seek to expand our work.

Date

14 December 2021

Download the Strategic Direction

Over the next five years, the Foundation will seek to mobilise the big players among the generic medicine manufacturers, vaccine manufacturers, diagnostics companies and medical gas companies – as well as continuing to drive change in Big Pharma.

The Strategic Direction includes quick-reads on each of these five essential healthcare sectors, outlining the specific challenges that need to be tackled, and how the Access to Medicine Foundation plans to motivate the pivotal players to move in the right direction. 

This short publication provides a guide to how our ‘model for change’ works in practice, laying out how the Foundation's tried-and-tested model has worked so far – and how we plan to leverage it to the fullest extent as we go forward.

Download the PDF to find out more, and to read what the experts say about the Access to Medicine Foundation and our work – with endorsements from leading figures such as Bill Gates, Mary Robinson, Dr Githinji Gitahi, Sir Andrew Witty, Dame Sally Davies, and Leith Greenslade.

Suzanne Wolf

Director of Communications

Get in touch

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved